|
US5571506A
(en)
|
1989-08-14 |
1996-11-05 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
|
|
WO1992020350A1
(en)
|
1991-05-20 |
1992-11-26 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
|
|
US6225352B1
(en)
|
1996-08-14 |
2001-05-01 |
Warner-Lambert Company |
Low molecular weight dendritic compounds as pharmaceutical agents
|
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
AU5300000A
(en)
|
1999-06-01 |
2000-12-18 |
Elan Pharma International Limited |
Small-scale mill and method thereof
|
|
US20040026546A1
(en)
|
2000-04-26 |
2004-02-12 |
Czekai David A |
Apparatus for sanitary wet milling
|
|
JPWO2001094309A1
(ja)
|
2000-06-02 |
2004-02-05 |
塩野義製薬株式会社 |
Ｐｇｄ２／ｔｘａ２両受容体拮抗性医薬組成物
|
|
CA2415900A1
(en)
|
2000-07-14 |
2002-01-31 |
The Uab Research Foundation |
Uses for nad synthetase inhibitors
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
US6656971B2
(en)
|
2001-01-25 |
2003-12-02 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
US6976647B2
(en)
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
|
JP4223390B2
(ja)
|
2001-06-05 |
2009-02-12 |
エラン・ファルマ・インターナショナル・リミテッド |
材料をフライス削りするシステムおよび方法
|
|
WO2003006628A2
(en)
|
2001-07-13 |
2003-01-23 |
Virtual Drug Development, Inc. |
Nad synthetase inhibitors and uses thereof
|
|
US20040157919A1
(en)
|
2002-01-25 |
2004-08-12 |
Yong-Qian Wu |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
ATE487470T1
(de)
|
2002-09-11 |
2010-11-15 |
Elan Pharma Int Ltd |
Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse
|
|
WO2004099127A1
(en)
|
2003-05-07 |
2004-11-18 |
Novo Nordisk A/S |
Novel compounds as kinase inhibitors
|
|
EP1626742A1
(en)
|
2003-05-22 |
2006-02-22 |
Elan Pharma International Limited |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
JPWO2005012221A1
(ja)
|
2003-08-04 |
2006-09-14 |
小野薬品工業株式会社 |
ジフェニルエーテル化合物、その製造方法および用途
|
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
US7544699B2
(en)
|
2003-08-08 |
2009-06-09 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
EP1836182A2
(en)
|
2004-11-18 |
2007-09-26 |
The Institutes for Pharmaceutical Discovery, LLC |
Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
|
|
US20090124654A1
(en)
|
2005-03-01 |
2009-05-14 |
Mjalli Adnan M M |
Aryl and Heteroaryl Compounds, Compositions, Methods of Use
|
|
PL2003132T3
(pl)
|
2006-04-03 |
2014-10-31 |
Astellas Pharma Inc |
Pochodne oksadiazolu jako agoniści S1P1
|
|
US8969386B2
(en)
|
2007-05-09 |
2015-03-03 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
|
PT2303270T
(pt)
|
2008-05-05 |
2017-08-25 |
Sanofi Sa |
Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
EP3167875A1
(en)
|
2009-05-27 |
2017-05-17 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
CN112184094B
(zh)
|
2019-07-03 |
2024-08-20 |
北京京东振世信息技术有限公司 |
一种地址信息采集方法和装置
|
|
KR20220161476A
(ko)
|
2020-04-02 |
2022-12-06 |
호라이즌 테라퓨틱스 아일랜드 디에이씨 |
전신 경화증의 치료 방법
|
|
TW202227390A
(zh)
|
2020-08-31 |
2022-07-16 |
法商賽諾菲公司 |
結晶型edg-2受體拮抗劑及製造方法
|
|
US12391640B2
(en)
|
2022-03-02 |
2025-08-19 |
Horizon Therapeutics Ireland Dac |
Process of making a crystalline EDG-2 receptor antagonist
|